Vaccination

There is no vaccine against hepatitis C.

Prevention in the absence of vaccination

There are numerous studies with promising results that offer hope that a vaccine will be available in the future. In this context, at the present time, the most important prevention strategy is screening to identify infected people.

It is necessary to inform the population about the infection, the ways of transmission and the need for screening. The campaigns must aim in particular at the population groups at risk.

It should be taken into account that the main route of transmission is the blood route and occurs by blood transfusion incorrectly evaluated for the presence of the virus. Thus improving the screening of blood samples is very important.

Another source of infection is represented by injecting drug users. That is why implementing programmes to prevent drug use is essential. If the drug use exists, it is advisable to allow these subjects to access sterile syringes and needles. Studies have shown that by combining access to sterile syringes and treatment programs, it can be reduced by 80% the risk of drug users to become infected with HCV.

Administration of Immunoglobulins against hepatitis C

Prophylaxis with Immunoglobulins is not effective.

-->Dacă vă place acest articol, adăugați-l la Favorite (If you like this article, add it to your Favorites)